The Pentagon Now Writes the Space Investment Tape — $23B TTM, Doubled YoY

The Seraphim Space Index logged $23 billion of private investment in the trailing twelve months to Q2 2026, against $9.7 billion in the comparable year-earlier window — a 137% increase that the brief frames as "doubling." The quarterly cadence tells the same story with less ambiguity: $8 billion in Q1, $7.5 billion in Q2, an average deal size of $72.5 million and a median of $15 million, meaning the surge is broad-based, not driven by a single outlier. The biggest round in the dataset — True Anomaly's $600 million Series D — landed in April 2026 at a $2.2 billion valuation, with proceeds earmarked explicitly for Golden Dome space interceptors.

Set against that aggregate, the headline-friendly capital-markets event of the year — SpaceX's $75 billion Nasdaq IPO on June 12, 2026 at a $1.77 trillion valuation — starts to look like a sideshow. The IPO did not generate the investment surge; it rode one. BryceTech's Start-Up Space 2026 report found only $10.9 billion of start-up space investment in 2025, $7.3 billion of which (about two-thirds) was U.S.-domiciled and explicitly defense-linked. The Pentagon's Golden Dome, Starshield procurement, and SDA missile-tracking awards are the underlying gravity.

Congress allocated $23 billion for Golden Dome in the FY2026 defense appropriations bill; by March 2026, Breaking Defense and Reuters reported the Pentagon's internal total cost estimate had expanded to $185 billion, including a $10 billion acceleration package. The Space Force is now requesting $71.3 billion for FY2027 — more than double the $31.9 billion enacted for FY2026 — and Pentagon planners are targeting roughly $126 billion in national-security space outlays that fiscal year. Global military space spending is projected to cross $150 billion for the first time, with non-U.S. spending nearly doubling to $31.5 billion.

The awards are already flowing, and they are dispersing widely by design. In late April 2026, the Space Force's Space Systems Command announced twenty Other Transaction Authority agreements worth up to $3.2 billion across twelve companies for space-based interceptor prototypes: Anduril, Booz Allen Hamilton, General Dynamics Mission Systems, GITAI USA, Lockheed Martin, Northrop Grumman, Quindar, RTX (Raytheon), Sci-Tec, SpaceX, True Anomaly, and Turion Space. In July 2026, the Space Development Agency followed with $1.75 billion for 36 missile-tracking satellites, splitting $955 million to L3Harris and $798 million to Sierra Space. L3Harris also disclosed a separate $4.7 billion seven-year propulsion contract from Lockheed Martin supporting PAC-3 MSE interceptors.

SpaceX is the most visible proof point that defense demand — not retail enthusiasm — is the new marginal buyer of space capacity. The S-1 filed May 20, 2026 disclosed that Starlink ARPU fell 22% year over year as the subscriber base doubled to 12 million, yet Enterprise & Government connectivity revenue still rose to $1.806 billion in Q2 2026 from $867 million a year earlier (+108%). Starshield has accumulated more than $6 billion of multi-year U.S. government awards, primarily two Space Force contracts — the $2.29 billion Space Data Network Backbone award being the largest single piece. Total backlog at quarter end stood at $47.5 billion, and the cash pile reached $93.5 billion after the IPO.

The IPO itself was priced at $135 and opened at $150 (+11%) on June 12, closing day one at $161 (+19%) — at a $2.1 trillion market capitalization, the largest single-day equity debut in history. By the September 22 read, the shares were at $154.72 — barely above offer, with most of the post-IPO appreciation already given back on a 16.4% drawdown in late June. The market's verdict: investors will not pay growth multiples for a company whose marginal growth is now contract-dependent on Pentagon appropriations. Forward P/E sits at 204x against TTM revenue of $23 billion that is largely Starlink-plus-Starshield.

While U.S. headlines focused on the SpaceX IPO, India's space sector quietly doubled its private funding pace from $43 million in 2021 to $871 million across 285 companies in 2026 YTD, per the Tradeflock / NDTV compilation dated August 2026. Bengaluru has absorbed $495 million of that — roughly 57% — with Skyroot Aerospace, Pixxel, Agnikul Cosmos and Digantara leading the count. The capital structure mirrors the U.S. pattern: late-stage defense-adjacent rounds, not retail IPOs.

On the public side, India's Department of Space received ₹13,705.63 crore (about $1.64 billion) in the Union Budget for FY2026-27 — described in official commentary as a "modest funding hike" against the demand profile. The state-run prime, Hindustan Aeronautics, reported FY2026 revenue of about ₹32,250–33,050 crore and an order book that closed the year at ₹2.54 trillion (roughly $30 billion), a record. HAL's Q4 FY26 print: net profit ₹4,196 crore (+5.7% YoY) on revenue ₹13,942 crore (+1.8% YoY). HAL is the listed proxy for the SSLV technology transfer and the HAL–L&T consortium ISRO has tapped for launch infrastructure.

The capital cycle now has a clear two-tier structure. The Pentagon-funded incumbents — Lockheed Martin, RTX, Northrop Grumman, L3Harris, General Dynamics, Booz Allen Hamilton — are repricing backlog-to-revenue visibility, not growth. Lockheed lifted FY2026 sales guidance to $79.75–81.75 billion on a record $230 billion backlog and $65 billion in Q2 new orders, with the Space segment (its smallest, at ~17.6% of revenue) up 4.4% year over year. RTX posted $93.5 billion of TTM revenue with 14.5% quarterly growth driven by Raytheon's missile-defense portfolio. L3Harris and Northrop sit in the same gravitational field: profitable, low-teens multiples, growing backlogs from the same Golden Dome contracts.

The pure-plays trade differently. Rocket Lab closed at $71.98 against an analyst target of $109.37, with TTM gross margin of 37.3% and quarterly revenue growth of 62% — a valuation that prices in continued defense contract wins. The July–August $663 million in Space Force awards is the validation. Palantir, at a $434 billion market cap on $6.16 billion of TTM revenue (P/S 72x), is the data/AI layer riding the same thesis; its $127 million share of the Army's $192 million TITAN award is small dollars, big signaling. SpaceX, at $2.04 trillion and 88.5x sales, is the extreme case — a $75 billion IPO that already trades within striking distance of its offer.

The next four quarters are binary on contract flow. The FY27 Space Force $71.3 billion request goes through appropriations in late 2026 / early 2027; the SDA's Tranche 3 tracking layer (the 36-satellite $1.75 billion award) needs to translate into FY27–28 funded satellites; and the 12-company SBI prototype cohort will compete down to a smaller production set within ~24 months. Watch the next Space Systems Command OTA drop (likely Q4 2026 / Q1 2027) and the FY27 NDAA mark-up — those will reveal whether the $185 billion Golden Dome headline survives budget reconciliation.

The longer-term thesis depends on three things the Pentagon cannot fully control. First, Starlink commercial economics: if ARPU keeps sliding as subscribers scale, SpaceX capex (now $18 billion/quarter, much of it AI) becomes harder to justify without continued government purchase orders. Second, India-China tensions: India's space and missile-defense build-out is partly geopolitical, and a de-escalation would slow the parallel capital cycle. Third, valuation discipline: at $2 trillion and 88.5x sales, SpaceX already prices in continued execution; any pause in Starshield contract flow would compress the multiple quickly, and the late-June 16.4% drawdown shows the market will not look through stumbles.